These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis. Moreau R; Hadengue A; Pussard E; Soubrane O; Sogni P; Gaudin C; Lebrec D Hepatology; 1991 Dec; 14(6):1035-9. PubMed ID: 1835708 [TBL] [Abstract][Full Text] [Related]
3. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters]. Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293 [TBL] [Abstract][Full Text] [Related]
4. [The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis]. Tesar V; Petrtýl J; Jedlicka J; Horký K; Gregorová I; Kopecká J; Marek J; Marecek Z; Kordac V Cas Lek Cesk; 1990 Apr; 129(17):520-5. PubMed ID: 2140956 [TBL] [Abstract][Full Text] [Related]
5. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Henriksen JH; Bendtsen F; Gerbes AL; Christensen NJ; Ring-Larsen H; Sørensen TI Hepatology; 1992 Nov; 16(5):1163-70. PubMed ID: 1358779 [TBL] [Abstract][Full Text] [Related]
6. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125 [TBL] [Abstract][Full Text] [Related]
7. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. Alvarez Kindelan A; Pérez Navero JL; Ibarra de la Rosa I; Concha Ruiz M; Montilla López P; Romanos Lezcano A Crit Care Med; 1994 Nov; 22(11):1754-61. PubMed ID: 7956278 [TBL] [Abstract][Full Text] [Related]
8. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J; Kravetz D; Rodes J Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [TBL] [Abstract][Full Text] [Related]
9. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197 [TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. Arendt RM; Gerbes AL; Ritter D; Stangl E; Bach P; Zähringer J J Hypertens Suppl; 1986 Jun; 4(2):S131-5. PubMed ID: 2941536 [TBL] [Abstract][Full Text] [Related]
11. Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor99-126 in patients with cirrhosis. Henriksen JH; Bendtsen F; Schütten HJ; Warberg J Am J Gastroenterol; 1990 Sep; 85(9):1155-9. PubMed ID: 2143885 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [TBL] [Abstract][Full Text] [Related]
14. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Piscaglia F; Zironi G; Gaiani S; Mazziotti A; Cavallari A; Gramantieri L; Valgimigli M; Bolondi L Hepatology; 1999 Jul; 30(1):58-64. PubMed ID: 10385639 [TBL] [Abstract][Full Text] [Related]
15. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver]. Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181 [TBL] [Abstract][Full Text] [Related]
16. [Relations between ACE inhibition with captopril and atrial natriuretic factor during an acute hemodynamic study]. Mangieri E; Croce CT; Ferraironi A; Salvati A; Sardella GM; Greco C; Avella A; Berni A; Nigri A; Reale A Cardiologia; 1991 Apr; 36(4):295-8. PubMed ID: 1834331 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. McCormick PA; Chin J; Greenslade L; Karatapanis S; Dick R; McIntyre N; Burroughs AK Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631 [TBL] [Abstract][Full Text] [Related]
18. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. Hollister AS; Rodeheffer RJ; White FJ; Potts JR; Imada T; Inagami T J Clin Invest; 1989 Feb; 83(2):623-8. PubMed ID: 2521490 [TBL] [Abstract][Full Text] [Related]
19. [Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis]. Hartleb M; Kirstetter P; Moreau R; Soupison T; Pussard E; Hadengue A; Sogni P; Gaudin C; Lebrec D Gastroenterol Clin Biol; 1994; 18(5):407-12. PubMed ID: 7813855 [TBL] [Abstract][Full Text] [Related]
20. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Tietge UJ; Böker KH; Manns MP; Bahr MJ Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]